Krka buys 4,808 shares of Krka stock, lifting holdings to 7.853 percent
Published on 10/20/2026 at 13:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBuyback and earnings calendar
- Krka acquired 4,808 treasury shares between October 9 and October 15, 2026.
- First-half 2026 revenue reached EUR 1,119.3 million, up 7.00 percent year over year.
- Krka stock traded at EUR 256.25 at 1:04 p.m. CEST on October 20, 2026.
- Krka's third-quarter 2026 earnings release is scheduled for November 12, 2026.
Krka, d. d. (ISIN SI0031102120) bought 4,808 of its own shares worth EUR 1,236,695 between October 9 and October 15, 2026, according to MarketScreener. The transactions lifted Krka's treasury holdings from 7.838 percent to 7.853 percent of issued shares.
Buyback adds 4,808 shares
The purchase took place on the Ljubljana Stock Exchange over five trading dates. Krka acquired 1,015 shares on October 9, 986 on October 12, 866 on October 13, 990 on October 14 and 951 on October 15, 2026. The weighted average prices ranged from EUR 255.63 to EUR 258.49, according to MarketScreener.
The latest tranche extends a buyback program first referenced in Krka's July 20, 2026 public notice. For investors, the increase from 7.838 percent to 7.853 percent provides the clearest quantified measure of the program's progress.
What does the buyback mean?
The immediate financial effect is modest in relation to the company's operating base, but the disclosed share count gives the program a concrete scale. Krka's first-half 2026 results showed revenue of EUR 1,119.3 million, up 7 percent from the same period a year earlier, while net profit rose 5 percent to EUR 260.2 million, according to Krka. The company describes prescription pharmaceuticals, non-prescription products and animal health products as its core businesses.
Three dates frame the story
On July 9, 2026, Krka reported that its annual general meeting had reviewed the 2025 annual report, according to Krka. On July 23, 2026, the company published first-half results with EUR 1,119.3 million in revenue and EUR 260.2 million in net profit, according to Krka. On October 16, 2026, it disclosed the latest 4,808-share tranche, as reported by MarketScreener.
Next reporting date is November 12
The next scheduled date is November 12, 2026, when Krka is listed as due to release third-quarter results. That date gives the buyback activity a near-term reporting marker and creates the next confirmed operating checkpoint for the stock.
Stock price stays at EUR 256.25
Krka stock was trading at EUR 256.25 at Lang & Schwarz on October 20, 2026 at 1:04 p.m. CEST. The current euro quotation gives German investors a live reference alongside the company's Ljubljana listing.
The further course of trading is shown by the continuously updated real-time quote of Krka stock.
Krka stock key data
- Company: Krka, d. d.
- ISIN: SI0031102120
- Ticker: KRKG
- Primary exchange: Ljubljana Stock Exchange
- Price Lang & Schwarz (as of October 20, 2026, 1:04 p.m. CEST): EUR 256.25
- Sector / Industry: Healthcare / Pharmaceuticals
Market context: Market report Euro Stoxx 50.
